NCT05220553

Brief Summary

The finger and fingertip are the most frequently amputated body parts, due to work-related incidents. Yet because of space, weight and cost constraints, prosthetic fingers and fingertips are heavy and bulky with limited active motion and sensation. Most are basic variations on the hook and claw. Lower limb prostheses have become extremely technologically advanced in their design and materials, and upper limbs lag behind in all of these areas. This is due to the complexity of the anatomy and function of the upper limb compared to the lower. There are no commercially available prostheses that offers direct sensory feedback and as such, rely on visual feedback from the wearer. The original PROLIMB study (PROLIMB I) used a Leap Motion Controller (LMC) to investigate the type of grasp adaptation that have been undertaken by patients during the rehabilitation process following amputation and compared this to similar data from healthy volunteers. PROLIMB I also looked at refining the tactile feedback system by investigating the sensation felt on amputation sites in order to feed this information into the haptic feedback system. The vision of the PROLIMB II project is to build on the work completed in PROLIMB I and develop and combine mechanistic models of hand motion and haptic sensing to deliver novel, affordable body-powered prosthetic fingertip digits with enhanced motion and sensation to address current clinical needs and support the quality of life of amputees. With collaboration from the University of Warwick (UoW) and University College London (UCL), Steeper Group and Naked Prosthetics the PROLIMB II study will aim to model, design, fabricate and validate a body-powered prosthetic fingertip digit with integrated sensory feedback. The University Hospital Coventry \& Warwickshire (UHCW) will provide the clinical facility with which to assess the comfort, usability and acceptance of this prosthetic in the daily lives of patients with digit amputations. This project will be a proof of concept study with verification of the prosthetic in motion capture (gait) laboratories as well as the use of simple validation data collection over a longer period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

July 10, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2024

Completed
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

January 6, 2022

Last Update Submit

March 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To test the feasibility of using the PROLIMB II prosthesis for patients who have suffered recent finger/thumb digit amputations

    Number of patients screened, recruited, withdrawn, retained and deemed suitable for using the PROLIMB II prosthesis.

    24 months

Secondary Outcomes (6)

  • To demonstrate a difference in the performance when using the PROLIMB II prosthesis for simple daily motor tasks vs when completing without

    24 months

  • To show a change in the fine motor skills of participants during the study using the VICON Motion Capture System.

    24 months

  • Number of patients that show an acceptabilitys to use the PROLIMB II prosthesis in their daily lives using the QuickDASH questionnaire

    24 months

  • Number of patients that show an acceptabilitys to use the PROLIMB II prosthesis in their daily lives using teh TAPES-R outcome measure

    24 months

  • To show a change in the levels of sensation felt by the participant when using the prosthetic via the two point discrimination measure

    24 months

  • +1 more secondary outcomes

Study Arms (1)

Prosthesis

EXPERIMENTAL

Participants will be given the PROLIMB II prosthesis to trial in our lab and in their daily lives

Device: PROLIMB Prosthesis

Interventions

Participants will be given the PROLIMB prosthesis to test in the lab and to use in their daily lives

Prosthesis

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 or older
  • Had a previous unilateral finger/thumb digit(s) amputated (through accident or surgery) within the 12 months before consenting into the PROLIMB II study.
  • Amputated distal to proximal phalange/metacarpal joint
  • Have capacity to provide informed consent

You may not qualify if:

  • Have been frequently using an alternative prosthetic for their digit amputations for over 1 month.
  • Still receiving active treatment or rehabilitation or healing for their residual digits at the time of screening.
  • Patients who are amputated at or proximal to the proximal phalange/metacarpal joint.
  • Allergic or hypersensitive to the material in contact with the skin
  • Evidence of neuroma causing point hypersensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Coventry and Warwickshire NHS Trust

Coventry, West Midlands, CV22DX, United Kingdom

Location

MeSH Terms

Conditions

Prosthesis Failure

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Feasibility Pilot Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2022

First Posted

February 2, 2022

Study Start

July 10, 2023

Primary Completion

August 16, 2024

Study Completion

August 16, 2024

Last Updated

March 24, 2025

Record last verified: 2025-03

Locations